Article Details

Repare relinquishes cancer drug to Roche, gets $125M to finance growing pipeline

Retrieved on: 2022-06-02 15:28:10

Tags for this article:

Click the tags to see associated articles and topics

Repare relinquishes cancer drug to Roche, gets $125M to finance growing pipeline. View article details on hiswai:

Excerpt

Roche's deep oncology pipeline is adding a drug candidate from Repare Therapeutics that works by interfering with a DNA repair mechanism of cancer ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up